RecruitingHypertensionHypertension Complicated With Type 2 Diabetes
Integrating Free-choice Marketplace, dieTitian coacHing, cultuRally Tailored messagIng to improVE Blood Pressure
Eligible age
21–70 yrs
Accepts
All genders
Locations
1 state
Healthy volunteers
Yes
See if you qualify for this study
Answer a few quick questions about your location and health. Takes about a minute.
About this study
iTHRIVE intervention is a 2-arm randomized controlled trial testing the effects of digital FARMacy, personalized dietitian coaching with produce prescriptions, and home blood pressure measurement in 100 hypertensive adults living in high food priority areas in counties in Maryland.
Sponsor: Johns Hopkins University
You may qualify if…
- ✓ 21-70 years
- ✓ Self-identify as Black/African American or Hispanic/Latino
- ✓ Have Stage 2 CKM defined as:
- ✓ Systolic BP ≥130mmHg (measured at screening) AND at least one of:
- ✓ Hypertension (ICD-10: I10-I16)
- ✓ Prediabetes (HbA1c 5.7-6.4%) or Type 2 Diabetes (HbA1c ≥6.5%)
- ✓ Stage 3 chronic kidney disease (CKD) (eGFR 30-59 mL/min/1.73m²)
- ✓ Live in census tracts identified by the Montgomery/ Prince George's/Baltimore City County Departments of Planning as HFPA:
You may not qualify if…
- ✕ Age \<21 years
- ✕ Diagnosis of end-stage renal disease (ESRD), dialysis
- ✕ Serious medical condition that either limits life expectancy or requires active management (e.g., cancer)
- ✕ Significant food allergies, preferences, intolerances, or dietary requirements that would interfere with diet adherence
- ✕ Active alcohol or substance use disorder (i.e., not sober/abstinent for ≥ 30 days)
- ✕ Patients with cognitive impairment or other condition preventing their participation in the intervention
- ✕ Pregnant, breastfeeding, or planning pregnancy
- ✕ Current participation in a care management program related to health conditions (e.g., weight reduction, smoking cessation) or another clinical trial that could interfere with the study protocol
Where it's recruiting
Maryland
Baltimore · Gaithersburg
Source: ClinicalTrials.gov · NCT07075588 · last updated 2026-06-30